Bone grafts and substitutes are implantable materials used for replacing missing bones or repairing bone fractures. Their osteogenic, osteoinductive, & osteoconductive characteristics facilitate faster bone healing & formation and osseous restoration. They are used extensively in bone injuries and the ankle, foot, hip surgeries & fractures. The various types of bone grafts & substitutes include allografts, autografts, synthetic, or xenografts. The rising cases of orthopedic surgeries owing to sports injuries & road accidents have led to the surging utilization of these materials worldwide.
The Global Bone Grafts And Substitutes Market is projected to grow at a CAGR of around 5.6% during the forecast period, i.e., 2022-27. The growth of the market is driven primarily by the increasing prevalence of orthopedic trauma & osteoarthritis and various advancements in bone grafts & substitutes like the launch of biocompatible synthetic grafts to reduce adverse reactions after surgeries.
Bone & joint disorders adversely impact the musculoskeletal system, which comprises bones, tendons, soft tissues, ligaments, & muscles that function together to support the body's weight and help an individual move. As a result, the leading market players are investing substantially in developing new products with better bioactivity, biocompatibility, & suitable mechanical properties.
|Study Period||Historical Data: 2017-20|
|Base Year: 2021|
|Forecast Period: 2022-27|
|Regions Covered||North America: USA, Canada, Mexico|
|Europe: Germany, The UK, Germany, France, Spain, Italy and Others|
|Asia-Pacific: China, India, Japan, South Korea, Australia and Others|
|South America: Brazil, Rest of South America|
|Middle East & Africa: South Africa and Others|
|Key Companies Profiled||AlloSource, Baxter, Biobank, DePuy Synthes, Inc., Geistlich Pharma AG, Medtronic, NuVasive, Inc., OST Développement, Smith & Nephew, Inc., Stryker Corporation, TBF Tissue Engineering, Wright Medical Group N.V., Zimmer Biomet|
|Unit Denominations||USD Million/Billion|
Besides, the rapidly expanding geriatric population, growing inclination toward minimally invasive surgeries, and the mounting awareness among patients about the benefits of bone regeneration through biologics are further augmenting the growth of the bone grafts & substitutes market.
In addition, the extensive availability of advanced bone grafts & substitutes materials in different shapes & sizes, the surging number of patients with orthopedic & periodontal diseases, and massive R&D investments in enhancing the bioactivity of bone grafts and substitutes are other crucial aspects projected to drive the global market in the coming years.